Savara Inc. SVRA
$5.26
▼ -0.19% 24H
About
Savara Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for rare and chronic respiratory diseases. Dedicated to addressing unmet medical needs, Savara Inc. aims to bring innovative treatment options to patients with limited therapeutic choices. One of their primary devel…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees59
TickerSVRA
Statistics
Market Cap$1.08B
Revenue (TTM)—
Net Income-$118.8M
Net Margin—
EPS$-0.53
P/E-9.93
P/S—
P/B6.35
EV/EBITDA-8.38
ROE-80.0%
Dividend Yield—
Price$5.26
Data: Twelve Data · Revenue = mcap / P/S